摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-ethynyl-N-methylpyridazin-3-amine

中文名称
——
中文别名
——
英文名称
6-ethynyl-N-methylpyridazin-3-amine
英文别名
——
6-ethynyl-N-methylpyridazin-3-amine化学式
CAS
——
化学式
C7H7N3
mdl
——
分子量
133.15
InChiKey
VCCNQLLCIHJQFA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    37.8
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Protein Kinase Inhibitors
    申请人:ASTAR BIOTECH LLC
    公开号:US20140364436A1
    公开(公告)日:2014-12-11
    The present invention relates to compounds of Formula VIII with absolute configuration R or S: as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula VIII, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.
    本发明涉及具有绝对构型R或S的VIII式化合物,以及其药学上可接受的盐、合物或溶剂化物,其中变量在此描述。本发明还涉及包括VIII式化合物的制药组合物,以及抑制蛋白激酶的方法和治疗疾病的方法,例如癌症、炎症等。
  • US9174996B2
    申请人:——
    公开号:US9174996B2
    公开(公告)日:2015-11-03
  • [EN] PROTEIN KINASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINES KINASES
    申请人:ASTAR BIOTECH LLC
    公开号:WO2014019338A1
    公开(公告)日:2014-02-06
    Disclosed are compounds of Formula I, as well as pharmaceutically acceptable salts, hydrates, isomers, or solvates thereof. Also disclosed are pharmaceutical compositions which comprise the compounds of Formula I, and methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.
  • [EN] PROTEIN KINASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINE KINASE
    申请人:ASTAR BIOTECH LLC
    公开号:WO2016029776A1
    公开(公告)日:2016-03-03
    The compounds of Formula (VIII) with absolute configuration R or S, as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The pharmaceutical compositions which comprise the compounds of Formula (VIII), and methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation are provided.
查看更多